Back
 JBM  Vol.6 No.1 , January 2018
Epstein Bar Virus—The Cause of Hodgkin’s Lymphoma
Abstract: Objective: Epstein-Barr virus (EBV), a herpes virus which persists in memory B cells in the peripheral blood for the lifetime of a person, is accused to be associated with several malignancies. Hodgkin’s lymphoma (HL) has long been suspected to have an Epstein-Barr virus infection as a causal agent. Some recent studies identified an EBV latent infection to a high degree in Hodgkin’s lymphoma. However, despite intensive study, the role of Epstein-Barr virus infection in Hodgkin lymphoma remains enigmatic. Methods: To explore the cause-effect relationship between EBV and HL and so to understand the role of EBV in HL etiology more clearly, a systematic review and re-analysis of studies published is performed. The method of the conditio per quam relationship was used to proof the hypothesis if Epstein-Barr virus infection (DNA) in human lymph nodes is present then Hodgkin lymphoma is present too. The mathematical formula of the causal relationship k was used to proof the hypothesis, whether there is a cause effect relationship between an Epstein-Barr virus infection (EBV DNA) and Hodgkin lymphoma. Significance was indicated by a p-value of less than 0.05. Result: The data analyzed support the Null-hypotheses that if Epstein-Barr virus infection (EBV DNA) is present in human lymph nodes then Hodgkin lymphoma is present too. In the same respect, the studies analyzed provide highly significant evidence that Epstein-Barr virus the cause of Hodgkin lymphoma. Conclusion: The findings of this study suggest that Epstein-Barr virus is the cause of Hodgkin’s lymphoma besides of the complexity of Hodgkin’s disease.
Cite this paper: Barukčić, I. (2018) Epstein Bar Virus—The Cause of Hodgkin’s Lymphoma. Journal of Biosciences and Medicines, 6, 75-100. doi: 10.4236/jbm.2018.61008.
References

[1]   Epstein, M.A., Achong, B.G. and Barr, Y.M. (1964) Virus Particles in Cultured Lymphoblasts from Burkitt’s Lymphoma. Lancet, 283, 702-703.
https://doi.org/10.1016/S0140-6736(64)91524-7

[2]   Cohen, J.I. (2000) Epstein-Barr Virus Infection. The New England Journal of Medicine, 343, 481-492.
https://doi.org/10.1056/NEJM200008173430707

[3]   Meij, P., Vervoort, M.B., Aarbiou, J., van Dissel, P., Brink, A., Bloemena, E., Meijer, C.J. and Middeldorp, J. (1999) Restricted Low-Level Human Antibody Responses against Epstein—Barr Virus (EBV)—Encoded Latent Membrane Protein 1 in a Subgroup of Patients with EBV-Associated Diseases. The Journal of Infectious Diseases, 179, 1108-1115.
https://doi.org/10.1086/314704

[4]   zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P. and Santesson, L. (1970) EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx. Nature, 228, 1056-1058.
https://doi.org/10.1038/2281056a0

[5]   Golden, R.L. (1968) Infectious Mononucleosis with Epstein-Barr Virus Antibodies in Older Ages. JAMA: The Journal of the American Medical Association, 205, 595.
https://doi.org/10.1001/jama.1968.03140340065021

[6]   Kapatai, G. and Murray, P. (2007) Contribution of the Epstein-Barr Virus to the Molecular Pathogenesis of Hodgkin Lymphoma. Journal of Clinical Pathology, 60, 1342-1349.
https://doi.org/10.1136/jcp.2007.050146

[7]   Hodgkin, T. (1832) On Some Morbid Experiences of the Absorbent Glands and Spleen. Medico-Chirurgical Transactions, 17, 69-97.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2116706/

[8]   Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., et al. (1994) A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
https://www.ncbi.nlm.nih.gov/pubmed/8068936

[9]   Sternberg, C. (1898) über Eine Eigenartige Unter Dem Bilde Der Pseudoleukamie Verlaufende Tuberculose Des Lymphatischen Apparates. Zeitschrift für Heilkunde, 19, 21-90.

[10]   Reed, D. (1902) On the Pathological Changes in Hodgkin’s Disease, with Special Reference to Its Relation to Tuberculosis. The Johns Hopkins Hospital Reports, 10, 133-196.

[11]   Küppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R. and Hansmann, M.L. (1994) Hodgkin Disease: Hodgkin and Reed-Sternberg Cells Picked from Histological Sections Show Clonal Immunoglobulin Gene Rearrangements and Appear to Be Derived from B Cells at Various Stages of Development. Proceedings of the National Academy of Sciences of the United States of America, 91, 10962-10966.
https://doi.org/10.1073/pnas.91.23.10962

[12]   Newell, G.R. and Rawlings, W. (1972) Evidence for Environmental Factors in the Etiology of Hodgkin’s Disease. Journal of Chronic Diseases, 25, 261-267.
https://doi.org/10.1016/0021-9681(72)90162-2

[13]   Goldman, J.M. and Aisenberg, A.C. (1970) Incidence of Antibody to EB Virus, Herpes Simplex, and Cytomegalovirus in Hodgkin’s Disease. Cancer, 26, 327-331.
https://doi.org/10.1002/1097-0142(197008)26:2<327::AID-CNCR2820260213>3.0.CO;2-8

[14]   Levine, P.H. (1970) E.B. Virus and Lymphomas. Lancet, 296, 771.
https://doi.org/10.1016/S0140-6736(70)90243-6

[15]   Levine, P.H., Ablashi, D.V., Berard, C.W., et al. (1971) Elevated Antibody Titers to Epstein-Barr Virus in Hodgkin’s Disease. Cancer, 27, 416-421.
https://doi.org/10.1002/1097-0142(197102)27:2<416::AID-CNCR2820270227>3.0.CO;2-W

[16]   Weiss, L.M., Strickler, J.G., Warnke, R.A., Purtilo, D.T. and Sklar, J. (1987) Epstein-Barr Viral DNA in Tissues of Hodgkin’s Disease. American Journal of Pathology, 129, 86-91.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899692/

[17]   Dinand, V., Dawar, R., Arya, L.S., Unni, R., Mohanty, B. and Singh, R. (2007) Hodgkin’s Lymphoma in Indian Children: Prevalence and Significance of Epstein-Barr Virus Detection in Hodgkin’s and Reed-Sternberg Cells. European Journal of Cancer, 43, 161-168.
https://doi.org/10.1016/j.ejca.2006.08.036

[18]   Chae, Y.K., Arya, A., Chiec, L., Shah, H., Rosenberg, A., Patel, S., Raparia, K., Choi, J., Wainwright, D.A., Villaflor, V., Cristofanilli, M. and Giles, F. (2017) Challenges and Future of Biomarker Tests in the Era of Precision Oncology: Can We Rely on Immunohistochemistry (IHC) or Fluorescence In Situ Hybridization (FISH) to Select the Optimal Patients for Matched Therapy? Oncotarget, 8, 100863-100898.
https://doi.org/10.18632/oncotarget.19809

[19]   Coons, A.H., Creech, H.J. and Jones, R.N. (1941) Immunological Properties of an Antibody Containing a Fluorescent Group. Experimental Biology and Medicine, 47, 200-202.
https://doi.org/10.3181/00379727-47-13084p

[20]   Gall, J.G. and Pardue, M.L. (1969) Formation and Detection of RNA-DNA Hybrid Molecules in Cytological Preparations. Proceedings of the National Academy of Sciences of the United States of America, 63, 378-383.
https://doi.org/10.1073/pnas.63.2.378

[21]   Dinand, V., Sachdeva, A., Datta, S., Bhalla, S., Kalra, M., Wattal, C. and Radhakrishnan, N. (2015) Plasma Epstein Barr Virus (EBV) DNA as a biomarker for EBV-Associated Hodgkin Lymphoma. Indian Pediatrics, 52, 681-685.
https://doi.org/10.1007/s13312-015-0696-9

[22]   Barukcic, I. (1989) Die Kausalitat. Wissenschaftsverlag, Hamburg, 218.

[23]   Barukcic, I. (1997) Die Kausalitat. Scientia, Wilhelmshaven, 374.

[24]   Barukcic, I. (2005) Causality. New Statistical Methods. Books on Demand, Norderstedt, 488.

[25]   Barukcic, I. (2006) Causality. New Statistical Methods. Second English Edition, Books on Demand, Norderstedt, 488.

[26]   Barukcic, I. (2006) New Method for Calculating Causal Relationships. Proceeding of XXIIIrd International Biometric Conference, McGill University, Montréal, 16-21 July 2006, 49.

[27]   Barukcic, I. (2011) Causality I. A Theory of Energy, Time and Space. Lulu, Morrisville, NC, 648.

[28]   Barukcic, I. (2011) Causality II. A Theory of Energy, Time and Space. Lulu, Morrisville, NC, 376.

[29]   Barukcic, I. (2012) The Deterministic Relationship between Cause and Effect. International Biometric Conference, Kobe, Japan, 26-31 August 2012.
https://www.biometricsociety.org/conference-abstracts/2012/programme/p1-5/P-1/249-P-1-30.pdf

[30]   Barukcic, I. (2016) The Mathematical Formula of the Causal Relationship k. International Journal of Applied Physics and Mathematics, 6, 45-65.
https://doi.org/10.17706/ijapm.2016.6.2.45-65

[31]   Barukcic, K. and Barukcic, I. (2016) Epstein Barr Virus—The Cause of Multiple Sclerosis. Journal of Applied Mathematics and Physics, 4, 1042-1053.
https://doi.org/10.4236/jamp.2016.46109

[32]   Barukcic, I. (2016) Unified Field Theory. Journal of Applied Mathematics and Physics, 4, 1379-1438.
https://doi.org/10.4236/jamp.2016.48147

[33]   Barukcic, I. (2017) Helicobacter pylori—The Cause of Human Gastric Cancer. Journal of Biosciences and Medicines, 5, 1-19.
https://doi.org/10.4236/jbm.2017.52001

[34]   Barukcic, I. (2017) Anti Bohr—Quantum Theory and Causality. International Journal of Applied Physics and Mathematics, 7, 93-111.
https://doi.org/10.17706/ijapm.2017.7.2.93-111

[35]   Barukcic, I. (2017) Theoriae Causalitatis Principia Mathematica. Books on Demand, Norderstedt, 244.
https://www.bod.de/buchshop/theoriae-causalitatis-principia-mathematica-ilija-barukcic-9783744815932

[36]   Astorga, M.L. (2015) Diodorus Cronus and Philo of Megara: Two Accounts of the Conditional. Rupkatha Journal on Interdisciplinary Studies in Humanities, 7, 9-16.

[37]   Neyman, J. (1937) Outline of a Theory of Statistical Estimation Based on the Classical Theory of Probability. Philosophical Transactions of the Royal Society A, 236, 333-380.
https://doi.org/10.1098/rsta.1937.0005

[38]   Clopper, C. and Pearson, E.S. (1934) The Use of Confidence or Fiducial Limits Illustrated in the Case of the Binomial. Biometrika, 26, 404-413.
https://doi.org/10.1093/biomet/26.4.404

[39]   Agresti, A. and Coull, B.A. (1998) Approximate Is Better than “Exact” for Interval Estimation of Binomial Proportions. The American Statistician, 52, 119-126.
https://doi.org/10.2307/2685469

[40]   Leemis, L.M. and Trivedi, K.S. (1996) A Comparison of Approximate Interval Estimators for the Bernoulli Parameter. The American Statistician, 50, 63-68.
https://doi.org/10.2307/2685046

[41]   Louis, T.A. (1981) Confidence Intervals for a Binomial Parameter after Observing No Successes. The American Statistician, 35, 154.
https://doi.org/10.1080/00031305.1981.10479337

[42]   Hanley, J.A. and Lippman-Hand, A. (1983) If Nothing Goes Wrong, Is Everything All Right? JAMA: The Journal of the American Medical Association, 249, 1743-1745.
https://doi.org/10.1001/jama.1983.03330370053031

[43]   Jovanovic, B.D. and Levy, P.S. (1997) A Look at the Rule of Three. The American Statistician, 51, 137-139.
https://doi.org/10.1080/00031305.1997.10473947

[44]   Rumke, C.L. (1975) Implications of the Statement: No Side Effects Were Observed. The New England Journal of Medicine, 292, 372-373.
https://doi.org/10.1056/NEJM197502132920723

[45]   Fisher, R.A. (1922) On the Interpretation of X2 from Contingency Tables, and the Calculation of P. Journal of the Royal Statistical Society, 85, 87-94.
https://doi.org/10.2307/2340521

[46]   Pearson, K. (1900) On the Criterion That a Given System of Deviations from the Probable in the Case of a Correlated System of Variables Is Such That It Can Be Reasonably Supposed to Have Arisen from Random Sampling. Philosophical Magazine Series, 5, 157-175.
https://doi.org/10.1080/14786440009463897

[47]   Pearson, K. (1896) VII. Mathematical Contributions to the Theory of Evolution—III. Regression, Heredity, and Panmixia. Philosophical Transactions of the Royal Society of London Series A, 187, 253-218.
https://doi.org/10.1098/rsta.1896.0007

[48]   Pearson, K. (1904) Mathematical Contributions to the Theory of Evolution—XIII. On the Theory of Contingency and Its Relation to Association and Normal Correlation. Dulau and Co., London, 1-35.
https://archive.org/details/cu31924003064833

[49]   Hill, A.B. (1965) The Environment and Disease: Association or Causation? Proceedings of the Royal Society of Medicine, 58, 295-300.
https://doi.org/10.1177/0141076814562718

[50]   Woodward, M. (2014) Epidemiology: Study Design and Data Analysis. Third Edition, Taylor & Francis Group, LLC, Boca Raton, 819.

[51]   Martin-Subero, J.I., Gesk, S., Harder, L., et al. (2002) Recurrent Involvement of the REL and BCL11A Loci in Classical Hodgkin Lymphoma. Blood, 99, 1474-1477.
https://doi.org/10.1182/blood.V99.4.1474

[52]   Barth, T.F., Martin-Subero, J.I., Joos, S., et al. (2003) Gains of 2p Involving the REL Locus Correlate with Nuclear c-Rel Protein Accumulation in Neoplastic Cells of Classical Hodgkin Lymphoma. Blood, 101, 3681-3686.
https://doi.org/10.1182/blood-2002-08-2577

 
 
Top